Business · Companies · 10 hrs ago
Pharming reports strong quarterly results as new leaders keep strategy unchanged
Pharming reported strong quarterly results on Tuesday.
The biotechnology company’s new leaders are CFO Kenneth Lynard and CCO Leverne Marsh.
They took over a month ago from CEO Fabrice Chouraqui, who left unexpectedly.
The leadership change came just before the quarterly results were presented.
Lynard and Marsh say Pharming’s strategy will not change under their leadership.
Their message is that the company will continue with its existing strategy.
No further next steps are stated.
Pharming reported strong quarterly results.
The results came a month after Kenneth Lynard and Leverne Marsh took over as chief financial officer and chief commercial officer.
They replaced chief executive Fabrice Chouraqui, who had left unexpectedly.
The new leaders said Pharming’s strategy would remain unchanged.
- Who
- Pharming, led by chief financial officer Kenneth Lynard and chief commercial officer Leverne Marsh.
- What
- Pharming reported strong quarterly results, and its new leaders said the company’s strategy would not change.
- When
- Tuesday, about a month after Lynard and Marsh took over.
- Where
- Not stated.
- Why
- Not stated.
This story does not have two clearly opposing sides.
Kenneth Lynard and Leverne Marsh took over from chief executive Fabrice Chouraqui, who had left unexpectedly.
Pharming presented strong quarterly results, and the new leaders said its strategy would remain unchanged.
- Quarterly results
- Described as strong
- New chief financial officer
- Kenneth Lynard
- New chief commercial officer
- Leverne Marsh
- Former chief executive
- Fabrice Chouraqui, who left unexpectedly
1 source
What people are saying
Pharming’s strategy does not change